Novel treatment avenues for peripheral T-cell lymphomas

By Hopfinger Georg   Griessl Robert   Sifft Eveline   Taylor Ninon   Kenner Lukas   Greil Richard   Merkel Olaf  

Expert Opinion on Drug Discovery, Vol. 7, Iss. 12, 2012-12 ,pp. : 1149-1163

Informa Healthcare

Access to resources Recommend Favorite

A phase I study of everolimus and CHOP in newly diagnosed peripheral T-cell lymphomas

By Kim Seok   Kang Hye   Kim Jin   Eom Hyeon-Seok   Huh Jooryung   Ko Young   Lee Jongtae   Yim Dong-Seok   Lee Soo-Youn   Park Weon   Yang Woo   Lee Seung-Sook   Suh Cheolwon   Kim Won  

Investigational New Drugs, Vol. 31, Iss. 6, 2013-12 ,pp. : 1514-1521

Springer Publishing Company

Access to resources Recommend Favorite

The potential of pralatrexate as a treatment of peripheral T-cell lymphoma

By Dondi Alessandra   Bari Alessia   Pozzi Samantha   Ferri Paola   Sacchi Stefano  

Expert Opinion on Investigational Drugs, Vol. 23, Iss. 5, 2014-05 ,pp. : 711-718

Informa Healthcare

Access to resources Recommend Favorite

Dismal outcome of t‐cell lymphoma patients failing first‐line treatment: results of a population‐based study from the Modena Cancer Registry

By  

Hematological Oncology (Electronic), Vol. 33, Iss. 3, 2015-09 ,pp. : 147-151

John Wiley & Sons Inc

Access to resources Recommend Favorite

Dismal outcome of t‐cell lymphoma patients failing first‐line treatment: results of a population‐based study from the Modena Cancer Registry

By  

Hematological Oncology (Electronic), Vol. 278-0232, Iss. 3, 2015-09 ,pp. : 147-151

John Wiley & Sons Inc

Access to resources Recommend Favorite